Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Recruiting 2Completed 2Withdrawn 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Recurrence 2Neoplasms 2Melanoma 2Glioblastoma 2Vulvar Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Carcinoma, Anaplastic 1Skin Neoplasms 1Rectal Neoplasms 1Penile Neoplasms 1Mesothelioma, Malignant 1Head and Neck Neoplasms 1Gliosarcoma 1Glioma 1Ependymoma 1Disease Progression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1Carcinoma 1Advanced Squamous Non-Small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

pembrolizumab 4Cisplatin 4Blood Specimen Collection 4Cyclophosphamide 3130-nm albumin-bound paclitaxel 3fludarabine 2Tissue Banks 2Surgical Procedures, Operative 2Nivolumab 2Docetaxel 2tislelizumab 1fludarabine phosphate 1cemiplimab 1Therapeutics 1Surgical Flaps 1Standard of Care 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation Dose Hypofractionation 1Neoadjuvant Therapy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Low-Level Light Therapy 1Ketamine 1Immune Checkpoint Inhibitors 1Gastroscopy 1Etoposide 1Electric Stimulation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Head and Neck Neoplasms × cemiplimab × Clear all
NCT07179315 2026-03-04

A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

University of Chicago

Phase 2 Not yet recruiting
68 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡